United Therapeutics President and COO Benkowitz Buys and Sells Shares.

United Therapeutics Corporation (UTHR) has announced that Michael Benkowitz, the company's President and Chief Operating Officer, has made several transactions involving the purchase and sale of shares. On January 12, 2026, Benkowitz purchased 14,625 shares at a price of $117.76 per share and an additional 7,875 shares at a price of $146.03 per share. However, he subsequently sold 7,875 shares at $479.51 per share and another 14,625 shares at the same price.